China Resources Pharmaceutical Group Limited (FRA:640)

Market Cap	3.21B -5.4%
Revenue (ttm)	35.07B +4.3%
Net Income	535.40M +47.2%
EPS	0.09 +48.4%
Shares Out	n/a
PE Ratio	5.71
Forward PE	5.63
Dividend	0.03 (5.31%)
Ex-Dividend Date	Sep 10, 2026

Volume	n/a
Open	0.4960
Previous Close	0.4900
Day's Range	0.4960 - 0.4960
52-Week Range	0.4540 - 0.7100
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 24, 2026

About FRA:640

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular, metabolism, i...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Employees: 84,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 640

Financial Performance

In 2025, FRA:640's revenue was 269.57 billion, an increase of 4.62% compared to the previous year's 257.67 billion. Earnings were 4.04 billion, an increase of 21.34%.

Financial numbers in CNY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 24, 2026

Data Sources Report a data error